US Stock MarketDetailed Quotes
EVFM Evofem Biosciences
- 0.010
- 0.000-1.16%
15min DelayTrading Nov 26 15:01 ET
981.72KMarket Cap0.00P/E (TTM)
0.010High0.009Low862.83KVolume0.010Open0.010Pre Close8.09KTurnover0.86%Turnover Ratio0.20P/E (Static)100.33MShares0.22652wk High-0.01P/B981.68KFloat Cap0.00652wk Low--Dividend TTM100.33MShs Float23550.000Historical High--Div YieldTTM12.12%Amplitude0.006Historical Low0.009Avg Price1Lot Size
About Evofem Biosciences Company
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
Company Profile
SymbolEVFM
Company NameEvofem Biosciences
Listing DateNov 20, 2014
Issue Price14.00
Founded2007
CEOMs. Saundra Pelletier
MarketPink Market
Employees38
Fiscal Year Ends12-31
Address7770 Regents Road,Suite 113-618
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92122
Phone1-858-550-1900
Websitehttp://www.evofem.com
Company Executives
- Name
- Position
- Salary
- Saundra Pelletier
- Interim Chairman of the Board, President and Chief Executive Officer
- --
- Justin J. File
- Chief Financial Officer and Principal Accounting Officer
- --
- Tony O’Brien
- Independent Director
- --
- Colin Rutherford
- Independent Director
- --
- Dr. Lisa Dale Rarick, F.A.C.O.G.
- Independent Director
- --
- Dr. Gillian Greer, PhD
- Independent Director
- --
- Jenny Yip
- Independent Director
- --
- Dr. Kim P. Kamdar
- Independent Director
- --
- Alexander A. Fitzpatrick, Esq.
- General Counsel and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data